Literature DB >> 18751378

Human papillomavirus frequency in oral and oropharyngeal cancer in Greece.

Mircea Romanitan1, Anders Näsman, Torbjörn Ramqvist, Hanna Dahlstrand, Leonidas Polykretis, Prokopis Vogiatzis, Periklis Vamvakas, Georgios Tasopoulos, Christos Valavanis, Petroula Arapantoni-Dadioti, Konstantinos Banis, Tina Dalianis.   

Abstract

UNLABELLED: The presence of human papillomavirus (HPV) was successfully analyzed by both general and type-specific HPV PCR in 103 samples from 115 patients diagnosed with oral and oropharyngeal cancer in Greece during the years 1986-2007.
RESULTS: In total 13/103 (13%) tumours were HPV-positive and the majority of these were HPV-16-positive. Of the tonsillar cancer samples, 12/28 (43%) were HPV-positive and, notably, 1/6 (17%) collected between 1992-1998 and 11/22 (50%) collected between 2000-2007 were HPV-positive. Of the tongue cancer samples, 1/38 (3%) were HPV-positive, while none of the 41 oral cavity cancer samples was HPV-positive.
CONCLUSION: Almost half of all the Greek tonsillar cancer patients had HPV in their tumours, with HPV-16 as the dominant type, and a tendency towards an increase in the proportion of HPV tumours was observed when comparing the percentage of HPV-positive tumours collected between 1992-1998 with those collected between 2000-2007.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751378

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

Review 2.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

Review 3.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

4.  Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.

Authors:  Benedikt Kramer; Johannes David Schultz; Clemens Hock; Alexander Sauter; Boris A Stuck; Karl Hörmann; Richard Birk; Christoph Aderhold
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

5.  Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain.

Authors:  L Cerezo; A de la Torre; A Hervás; A Ruiz; O Liñán; M López; K Villar; M Martín
Journal:  Clin Transl Oncol       Date:  2013-07-05       Impact factor: 3.405

6.  Effect of Bra Use during Radiotherapy for Large-Breasted Women: Acute Toxicity and Treated Heart and Lung Volumes.

Authors:  Lanea Keller; Randi Cohen; Dennis M Sopka; Tianyu Li; Linna Li; Penny R Anderson; Barbara L Fowble; Gary M Freedman
Journal:  Pract Radiat Oncol       Date:  2013-01-05

7.  A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas.

Authors:  Scott Murray; Michael N Ha; Kara Thompson; Robert D Hart; Murali Rajaraman; Stephanie L Snow
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-08-28

8.  Correlation of LMP10 expression and clinical outcome in Human Papillomavirus (HPV) positive and HPV-Negative tonsillar and base of tongue cancer.

Authors:  Nikolaos Tertipis; Linnea Haeggblom; Cecilia Nordfors; Nathalie Grün; Anders Näsman; Andrea Vlastos; Tina Dalianis; Torbjörn Ramqvist
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

9.  Positive Rate of Human Papillomavirus and Its Trend in Head and Neck Cancer in South Korea.

Authors:  Hyun Woong Jun; Yong Bae Ji; Chang Myeon Song; Jae Kyung Myung; Hae Jin Park; Kyung Tae
Journal:  Front Surg       Date:  2022-01-21

10.  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors:  George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal:  J Oncol       Date:  2009-12-29       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.